Revoderm Pharma is a medical-grade skincare line, representing the fusion of Dermatology with Laboratory Medicine. Founded in 2012 by Dr. Ken Alanen and Ildiko Juhasz, the company has invested five years in research and engineering to develop its ultimate cosmeceutical skincare line. Dr. Alanen, triple certified in Dermatology, Dermatopathology, and Laboratory Medicine, brings his expertise in clinical practice, molecular biology, and cosmetic dermatology to the venture. Ildiko Juhasz, with over a decade of experience in cosmetic medicine, enhances the team's knowledge base.
Revoderm's products are formulated with high-quality ingredients and fall within the cosmeceuticals category, blending prescription medicines with over-the-counter formulations. Available exclusively in medical clinics with extensively trained professionals, the company's comprehensive line of skincare products is designed to promote healthier skin and address a range of skin conditions, from acne to scar reduction. Prescribed by medical professionals, Revoderm corrects and addresses various skin conditions, restoring health, vitality, and beauty.
The company operates within the E-Commerce, Pharmaceutical, and Wellness Beauty industries. Although specific details about the headquarter location and recent investments are not currently available, Revoderm's focus on medical-grade skincare and its personalized approach to addressing skin issues positions it as an attractive prospect for potential investors in the health and wellness sector.
There is no investment information
No recent news or press coverage available for Revoderm Pharma.